Katharine Neill Harris

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing tax benefits and research opportunities, but recreational cannabis remains Schedule I. States with cannabis programs are awaiting further federal guidance, with some adjusting regulations to align with the new classification while maintaining existing laws.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing federal tax benefits and research opportunities. However, recreational marijuana remains Schedule I, and states with cannabis programs are awaiting further federal guidance. The DEA plans a hearing on potential de-scheduling of marijuana, but most state programs will likely continue unchanged.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to III, allowing federal tax benefits and research opportunities, but recreational cannabis remains Schedule I. States with medical or recreational programs await further federal guidance, with some, like Nevada and California, adjusting regulations to align with the rescheduling while maintaining existing state laws.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, enabling federal tax benefits and research opportunities. However, federal and state marijuana policy disparities persist, with recreational cannabis remaining Schedule I and states awaiting further guidance. The Drug Enforcement Administration will hold a hearing on potential broad de-scheduling by June.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to III, enabling tax benefits and research opportunities. However, federal and state marijuana policies remain conflicting, with recreational cannabis still classified as Schedule I. States like Nevada and California are adjusting regulations but await further federal guidance.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to III, allowing federal tax benefits and research opportunities, but federal and state cannabis policies remain divided. States like Nevada and California have acknowledged the change but emphasize their laws remain unchanged, awaiting further federal guidance.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing federal tax benefits and research opportunities, but recreational cannabis remains Schedule I. States with medical or recreational programs are navigating the shift while awaiting further federal guidance, as the DEA prepares to consider broader marijuana de-scheduling.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing tax benefits and research opportunities, but recreational marijuana remains Schedule I. States like Nevada and California are adjusting policies but await further federal guidance, as the DEA prepares to review broader marijuana de-scheduling.